No abstract

No abstract

Systemic administration of the 5‐HT2 agonist 1‐(2,5‐dimethoxy‐4‐iodophenyl)‐2‐aminopropane (DOI) (50 and 100 μg kg−1, i.v.) inhibited dorsal raphe neuronal firing. DOI (100 μg kg−1, i.v.) also produced a decrease in extracellular 5‐hydroxytryptamine (5‐HT) and 5‐hydroxyindoleacetic acid (5‐HIAA) in the frontal cortex measured by microdialysis. However, local administration of DOI into the frontal cortex produced no change in extracellular 5‐HT and 5‐HIAA at any dose given (1, 10 and 100 ng). The results demonstrate that DOI is a potent inhibitor of 5‐HT neuronal firing and terminal release and that the effects on release are not mediated by an action within the terminal region. The site of action and the receptor involved in the inhibition remains to be determined.

No abstract

No abstract